2010
 
 
 

2010:

 

Philipson, T. J., Lakdawalla D. N., & Goldman D. P. (2010). Addressing Geographic Variation and Health Care Efficiency. AEI. 

Shultz, K. S., Wang M., Crimmins E. M., & Fisher G. G. (2010). Age Differences in the Demand—Control Model of Work Stress An Examination of Data From 15 European Countries. Journal of Applied Gerontology. 29(1), 21-47.  

 Huesch, M. D., & Brady R. (2010). Allowing repeat winners. Judgment and Decision Making. 5(5), 374-379. 

 Frosch, D. L., Saxbe D., Janet A., Glenn B. A., Low C. A., Hanoch, iv Y., et al. (2010). Assessing the scholarly impact of health psychology: A citation analysis of articles published from 1993 to 2003. Health Psychology. 29(5), 555-562.  

 Antos, J., Bertko J., Chernew M. E., Cutler D. M., de Brantes F., Goldman D. P., et al. (2010). Bending the curve through health reform implementation. The American Journal of Managed Care. 16(11), 804-812. 

 Crimmins, E. M., Kim J. Ki, & Vasunilashorn S. (2010). Biodemography: New approaches to understanding trends and differences in population health and mortality. Demography. 47(1), S41-S64.  

 Vasunilashorn, S., Crimmins E. M., Kim J. Ki, Winking J., Gurven M., Kaplan H., et al. (2010). Blood lipids, infection, and inflammatory markers in the Tsimane of Bolivia. American Journal of Human Biology. 22(6), 731-740.  

 Chen, E., Looman M., Laouri M., Gallagher M., Van Nuys K., Lakdawalla D. N., et al. (2010). Burden of illness of diabetic macular edema: literature review. Current Medical Research and Opinion. 26(7), 1587-1597.  

 Edlin, A. S., & Goldman D. P. (2010). Can Immigrants Solve Our Health Care Problems? New York Times. 

 Smith, J. Patrick, & Goldman D. P. (2010). Can patient self-management explain the health gradient? Goldman and
Smith (2002) revisited: A response to Maitra. Social Science & Medicine. 70(6), 813-815. 

 Goldman, D. P., & Lakdawalla D. N. (2010). Can the ACA Improve Population Health? The Economists' Voice. 7(5).

 Hay, J. W., & Zhou Z-Y. (2010). Commentary on Knight et al.: A systematic review of the cost-effectiveness of rFVIIa and APCC in the treatment of minor/moderate bleeding episodes for haemophilia patients with inhibitors. Haemophilia. 16(2), 366-368.  

 Sun, E. C., Jena A. B., Lakdawalla D. N., Reyes C. M., Philipson T. J., & Goldman D. P. (2010). The 
Contributions of Improved Therapy and Earlier Detection to Cancer Survival Gains, 1988-2000: Forum for Health Economics & Policy. Forum for Health Economics and Policy. 13(2).

 Karaca-Mandic, P., Joyce G. F., Goldman D. P., & Laouri M. (2010). Cost Sharing, Family Health Care Burden, and the Use of Specialty Drugs for Rheumatoid Arthritis. Health Services Research. 45(5p1), 1227-1250.  

 Delavande, A., Goldman D. P., & Sood N. (2010). Criminal Prosecution and Human Immunodeficiency Virus–Related Risky Behavior. Journal of Law and Economics. 53(4), 741-782.  

 Oksuzyan, A., Crimmins E. M., Saito Y., O’Rand A., Vaupel J. W., & Christensen K. (2010). Cross-national comparison of sex differences in health and mortality in Denmark, Japan and the US. European Journal of Epidemiology. 25(7), 471-480. 

 Doctor, J. N., & Strylewicz G. (2010). Detecting ‘wrong blood in tube’ errors: Evaluation of a Bayesian network approach. Artificial Intelligence in Medicine. 50(2), 75-82. 

 Seeman, T. E., Merkin S. Stein, Crimmins E. M., & Karlamangla A. S. (2010). Disability Trends Among Older Americans: National Health and Nutrition Examination Surveys, 1988–1994 and 1999–2004. American Journal of Public Health. 100(1), 100-107. 

 Short, L. J., Fisher M. D., Wahl P. M., Kelly M. B., Lawless G. D., White S., et al. (2010). Disparities in medical care among commercially insured patients with newly diagnosed breast cancer. Cancer. 116(1), 193-202. 

 Lakdawalla, D. N., Sun E. C., Jena A. B., Reyes C. M., Goldman D. P., & Philipson T. J. (2010). An economic evaluation of the war on cancer. Journal of Health Economics. 29(3), 333-346. 

 Dwight-Johnson, M. D. Megan, Lagomasino M. D. Isabel, Hay J. W., Zhang L., Tang P. D. Lingqi, Green M. S. W. Jenn, et al. (2010). Effectiveness of Collaborative Care in Addressing Depression Treatment Preferences Among Low-Income
Latinos. Psychiatric Services. 

 Colla, C. Hoverman, Escarce J. J., Buntin M. Beeuwkes, & Sood N. (2010). Effects of Competition on the Cost and Quality of Inpatient Rehabilitation Care under Prospective Payment. Health Services Research. 45(6p2), 1981-2006. 
Lu, Y., & Goldman D. P. (2010). The Effects of Relative Food Prices on Obesity -- Evidence from China: 1991-2006. 

 Goldman, D. P., Vaiana M., & Romley J. A. (2010). The Emerging Importance of Patient Amenities in Hospital Care. New England Journal of Medicine. 363(23), 2185-2187. 

 Zissimopoulos, J. M., & Karoly L. A. (2010). Employment and self-employment in the wake of Hurricane Katrina. Demography. 47(2), 345-367. 

 Yu, A. P., Yu Y. F., & Nichol M. B. (2010). Estimating the Effect of Medication Adherence on Health Outcomes among Patients with Type 2 Diabetes—An Application of Marginal Structural Models. Value in Health. 13(8), 1038-1045. 

 Cai, L., Hayward M. D., Saito Y., Lubitz J., Hagedorn A., & Crimmins E. M. (2010). Estimation of multi-state life table functions and their variability from complex survey data using the SPACE Program. Demographic research. 22(6), 129-158. 

 Bhattacharya, J., Neuhauser F., Reville R. T., & Seabury S. A. (2010). Evaluating Permanent Disability Ratings Using Empirical Data on Earnings Losses. Journal of Risk and Insurance. 77(1), 231-260. 

 Strylewicz, G., & Doctor J. N. (2010). Evaluation of an automated method to assist with error detection in the ACCORD central laboratory. Clinical Trials. 

 Goldman, D. P., Michaud P-C., Lakdawalla D. N., Zheng Y., Gailey A. H., & Vaynman I. (2010). The Fiscal Consequences Of Trends In Population Health. National Tax Journal. 63(2), 307-30. 

 Cutler, D. M., Garber A. M., Goldman D. P., & Vogt W. B. (2010). Frontiers in Health Policy Research, volume 13. NBER Books. 

 Crimmins, E. M., Kim J. Ki, & Solé-Auró A. (2010). Gender differences in health: results from SHARE, ELSA and HRS. The European Journal of Public Health. 

 Philipson, T. J., Goldman D. P., Seabury S. A., Lakdawalla D. N., & Lockwood L. (2010). Geographic Variation in Health
Care: The Role of Private Markets. Brookings Papers on Economic Activity: Spring 2010. 325-355. 

 Mycka, J. M., Dellamano R., Kolassa E. Mick, Wonder M., Ghosh S., Hay J. W., et al. (2010). Good Research Practices for Measuring Drug Costs in Cost Effectiveness Analyses: An Industry Perspective: The ISPOR Drug Cost Task Force Report—Part V. Value in Health. 13(1), 25-27. 

 Hay, J. W., Smeeding J., Carroll N. V., Drummond M., Garrison L. P., Mansley E. C., et al. (2010). Good Research Practices for Measuring Drug Costs in Cost Effectiveness Analyses: Issues and Recommendations: The ISPOR Drug Cost Task Force Report—Part I. Value in Health. 13(1), 3-7. 

 Garrison, L. P., Mansley E. C., Abbott T. A., Bresnahan B. W., Hay J. W., & Smeeding J. (2010). Good Research Practices for Measuring Drug Costs in Cost-Effectiveness Analyses: A Societal Perspective: The ISPOR Drug Cost Task Force Report—Part II. Value in Health. 13(1), 8-13. 

 C. Mullins, D., Seal B., Seoane-Vazquez E., Sankaranarayanan J., Asche C. V., Jayadevappa R., et al. (2010). Good Research Practices for Measuring Drug Costs in Cost-Effectiveness Analyses: Medicare, Medicaid and Other US Government Payers Perspectives: The ISPOR Drug Cost Task Force Report—Part IV. Value in Health. 13(1), 18-24. 

 Shi, L., Hodges M., Drummond M., Ahn J., Li S. Chuen, Hu S., et al. (2010). Good Research Practices for Measuring Drug Costs in Cost-Effectiveness Analyses: An International Perspective: The ISPOR Drug Cost Task Force Report—Part VI. Value in Health. 13(1), 28-33. 

 Mansley, E. C., Carroll N. V., Chen K. S., Shah N. D., Piech C. Tak, Hay J. W., et al. (2010). Good Research Practices for Measuring Drug Costs in Cost-Effectiveness Analyses: A Managed Care Perspective: The ISPOR Drug Cost Task Force Report—Part III. Value in Health. 13(1), 14-17. 

 Michaud, P-C., Lakdawalla D. N., Goldman D. P., Sood N., & Cong Z. (2010). Health and Access Effects of New Drugs: Combining Experimental and Non-Experimental Data. Cahiers de recherche. 

 Doctor, J. N., Bleichrodt H., & H. Lin J. (2010). Health Utility Bias: A Systematic Review and Meta-Analytic Evaluation. Medical Decision Making. 30(1), 58-67. 

 Maestas, N., & Zissimopoulos J. M. (2010). How Longer Work Lives Ease the Crunch of Population Aging. Journal of Economic Perspectives. 24(1), 139-160. 

 Romley, J. A., Hackbarth A. D., & Goldman D. P. (2010). The Impact of Air Quality on Hospital Spending. 

 Johnson, K. A., Chen S., Cheng I.-N., Lou M., Gregerson P., Blieden C., et al. (2010). The impact of clinical pharmacy services integrated into medical homes on diabetes-related clinical outcomes. The Annals of Pharmacotherapy. 44(12), 1877-1886. 

 Zeng, F., An J J., Scully R., Barrington C., Patel B. V., & Nichol M. B. (2010). The Impact of Value-Based Benefit Design on Adherence to Diabetes Medications: A Propensity Score-Weighted Difference in Difference Evaluation. Value in Health. 13(6), 846-852. 

 Kymes, S. M., Plotzke M. R., Li J. Z., Nichol M. B., Wu J., & Fain J. (2010). The Increased Cost of Medical Services for People Diagnosed With Primary Open-Angle Glaucoma: A Decision Analytic Approach. American Journal of Ophthalmology. 150(1), 74-81. 

 Huesch, M. D. (2010). Managing Care? Medicare Managed Care and Patient Use of Cardiologists. Health Services Research. 45(2), 329-354. 

 Buntin, M. Beeuwkes, Colla C. Hoverman, Deb P., Sood N., & Escarce J. J. (2010). Medicare Spending and Outcomes after Post-Acute Care for Stroke and Hip Fracture. Medical care. 48(9), 776-784. 

 Knight, T. K. (2010). Nonadherence to clinical practice guidelines and medications for multiple chronic conditions in a California Medicaid population. Journal of the American Pharmacists Association. 50(4), 496. 

 Gailey, A. H., Lakdawalla D. N., & Sood N. (2010). Patents, innovation, and the welfare effects of Medicare Part D. Pharmaceutical Markets and Insurance Worldwide. 22, 317-344. 

 Benner, J. S., Nichol M. B., Rovner E. S., Jumadilova Z., Alvir J., Hussein M. A., et al. (2010). Patient-reported reasons for discontinuing overactive bladder medication. BJU International. 105(9), 1276-1282. 

 Huesch, M. D. (2010). Payment policy based on measurement of health care spending and outcomes. JAMA. 303(23),
2405-2406. 

 Wiegand, P., McCombs J. S., White J., & Wang J. J. (2010). PCV95 PREDICTIVE MODELS TO IDENTIFY NON-ADHERENCE TO DYSLIPIDEMIC MEDICATIONS USING PHARMACY AND MEDICAL CLAIMS DATA FROM A COMMERCIAL HEALTH PLAN. Value in Health. 13(3), A167-A168. 

 Zheng, Y., Goldman D. P., Michaud P-C., Lakdawalla D. N., Joyce G. F., Vaynman I., et al. (2010). PND37 PROJECTING THE BURDEN OF ALZHEIMER'S DISEASE AND EVALUATING THE POTENTIAL IMPACTS OF PREVENTING ALZHEIMER'S DISEASE IN THE UNITED STATES. Value in Health. 13(3), A144. 

 Perlroth, D. J., Goldman D. P., & Garber A. M. (2010). The potential impact of comparative effectiveness research on U.S. Health Care expenditures. Demography. 47(1), S173-S190. 

 Shang, B., & Goldman D. P. (2010). Prescription Drug Coverage and Medicare Spending among U.S. Elderly*. The Geneva Papers on Risk and Insurance - Issues and Practice. 35(4), 539-567. 

 Yoong, J., Burger N. E., Spreng C. P., & Sood N. (2010). Private Sector Participation and Health System Performance in Sub-Saharan Africa. PLoS ONE. 5(10), e13243. 

 Cunningham, P., Felland L. E., Ginsburg P. B., & Pham H. H. (2010). Qualitative Methods: A Crucial Tool for Understanding Changes in Health Systems and Health Care Delivery. Medical Care Research and Review. 

 Jena, A. B., Goldman D. P., Kamdar A., Lakdawalla D. N., & Lu Y. (2010). Sexually Transmitted Diseases Among Users of Erectile Dysfunction Drugs: Analysis of Claims Data. Annals of Internal Medicine. 153(1), 1-7. 

 Karlamangla, A. S., Merkin S. Stein, Crimmins E. M., & Seeman T. E. (2010). Socioeconomic and Ethnic Disparities in Cardiovascular Risk In the United States, 2001–2006. Annals of Epidemiology. 20(8), 617-628. 

 Penson, D. F., & Griebling T. L. (2010). Socioeconomic Factors, Urological Epidemiology and Practice Patterns. The Journal of Urology. 184(5), 1991-1994. 

 Crimmins, E. M., & Hagedorn A. (2010). The Socioeconomic Gradient in Healthy Life Expectancy. Annual Review of
Gerontology and Geriatrics. 30(1), 305-321. 

 Romley, J. A., Jena A. B., & Goldman D. P. (2010). Spending Intensity and Mortality in California Hospitals. 

 Philipson, T. J., Becker G., Goldman D. P., & Murphy K. (2010). Terminal Care and The Value of Life Near Its End. 
Reynolds, S. L., & Crimmins E. M. (2010). Trends in the ability to work among men and women in the older American population: 1997–2007. European Journal of Ageing. 7(4), 249-256. 

 Berenson, R. A., Ginsburg P. B., & Kemper N. (2010). Unchecked Provider Clout In California Foreshadows Challenges To Health Reform. Health Affairs.

 Joyce, G. F. (2010). Understanding Primary Nonadherence. The American journal of pharmacy benefits. 2(2), 111-118. 
 
Goldman, D. P., Jena A. B., Lakdawalla D. N., Malin J. L., Malkin J. D., & Sun E. C. (2010). The Value of Specialty Oncology Drugs. Health Services Research. 45(1), 115-132. 

 Goldman, D. P., Lakdawalla D. N., Philipson T. J., & Yin W. (2010). Valuing health technologies at nice: recommendations for improved incorporation of treatment value in HTA. Health Economics. 19(10), 1109-1116. 

 Ginsburg, P. B. (2010). Wide variation in hospital and physician payment rates evidence of provider market power. Research Brief. 1-11.